Merck: Glucophage Is the First Oral Diabetes Treatment Approved in Europe for Use During Pregnancy

In a European worksharing procedure (WSP), Glucophage was approved as the first oral anti-diabetic medication to be used safely from conception to birth. The approval was granted on the

Related Keywords

Norway ,United States ,Canada ,Poland ,Oliveira Baraldi ,Clin Pharmacokinet ,Maria Rivas ,Merck Press ,Women Health ,European Health ,Public Health ,International Journal Of Environmental Research ,National Health Statistics Reports Number ,National Health Fund ,Serono ,Journal Of Diabetes Research ,Chief Medical Officer ,Diab Res Care ,Tenth Edition ,International Journal ,Environmental Research ,Article Number ,National Health ,Health Statistics Reports Number ,Diabetes Research ,Diabetic Medicine ,Lancet Diabetes ,Ther Drug Monit ,Reprod Toxicol ,Banting Lecture ,British Journal ,Vascular Disease ,New England Journal ,Merck Press Releases ,Merck ,Lucophage ,First ,Mural ,Diabetes ,Treatment ,Approved ,Europe ,During ,Pregnancy ,